Navigation Links
Eurofins MWG Operon and Floragenex close co-marketing agreement for RAD discovery and RAD genotyping
Date:6/6/2013

Ebersberg, Germany and Portland, OR, USA, June 6, 2013 - Eurofins MWG Operon (Ebersberg, Germany) and Floragenex Inc. (Portland, OR, USA) have agreed to jointly market their respective expertise in next generation DNA sequencing and genomic services surrounding Restriction Site Associated DNA sequencing (RAD-Seq). RAD-Seq is an innovative genome sequencing protocol that facilitates cost-effective and fast SNP marker discovery and genotyping, especially in genetically complex or not well characterised organisms. The partnership will deliver comprehensive analysis results starting from consulting and DNA extraction through to genomic analysis. Together, the two companies will continue to serve a worldwide market for their products and services.

"In depth understanding of plants, animals and micro-organisms is essential for industrial and governmental organisations. Our clients appreciate our rapidly growing ability to advise and support them with integrated applied genomic solutions. Important service components include marker development, genotyping, genome analysis, transcriptomics, bioinformatics and support services. Floragenex' specific know-how in RAD-Sequencing and analysis is a strategic fit in this portfolio", says Bruno Poddevin, Eurofins Senior Vice President Genomic Services.

"As a leader in next generation sequencing technology and services, Eurofins' expertise in oligo production and NGS capacity is a perfect fit for our supply chain", says Rick Nipper, President of Floragenex. "This partnership will allow Floragenex to better serve customers already using RAD-Seq while also helping us to reach new clients around the globe."


'/>"/>

Contact: Dr. Georg Gradl
georggradl@eurofins.com
49-809-282-89945
Eurofins MWG Operon
Source:Eurekalert

Page: 1

Related biology news :

1. Eurofins MWG Operon reinforces NGS capability with Illumina HiSeq 2500 and Illumina MiSeq
2. Eurofins MWG Operon and Queen Mary, University Of London commence genome sequencing analysis of Ash
3. Rice, MD Anderson scientists probe mystery of operon evolution
4. U of Alberta researcher steps closer to understand autoimmune diseases
5. 24 new species of lizards discovered on Caribbean islands are close to extinction
6. Synthetic diamond steps closer to next generation of high performance electrochemical applications
7. The Iberian wolf lives close to humans more for refuge than for prey
8. Rise in temperatures and CO2 follow each other closely in climate change
9. Pilot Results Move GHX Closer to Delivery of Healthcare Industrys First Implantable Device Supply Chain Solution
10. Behind closed doors: Researchers show how probiotics boost plant immunity
11. Eyeless Australian fish have closest relatives in Madagascar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:5/12/2016)... DALLAS , May 12, 2016 ... has just published the overview results from the Q1 ... of the recent wave was consumers, receptivity to a ... wearables data with a health insurance company. ... choose to share," says Michael LaColla , CEO ...
(Date:5/3/2016)... , May 3, 2016  Neurotechnology, a provider ... MegaMatcher Automated Biometric Identification System (ABIS) , ... multi-biometric projects. MegaMatcher ABIS can process multiple complex ... any combination of fingerprint, face or iris biometrics. ... SDK and MegaMatcher Accelerator , which ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and Mold) microbial test has received AOAC Research Institute approval 061601. , “This ... introduced last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. ...
Breaking Biology Technology: